ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 1,210.00
+20.00 (1.68%)
Nov 2, 2026, 3:30 PM KST
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 35.87 billion as of October 30, 2026. It is the 34,586th most valuable company in the world and the 2,010th biggest in South Korea. Its market cap has decreased by 44.90% in one year.
Market Cap
35.87B
Enterprise Value
n/a
Revenue
59.09B
Global Rank
Country Rank
#2,010 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 35.87B, an increase of 14.96%. That is a compound annual growth rate of 0.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 35.87B | -49.67% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 132.38B |
| MedPacto | 120.82B |
| Genexine | 97.33B |
| Vaxcell-Bio Therapeutics | 92.10B |
| iNtRON Biotechnology | 85.88B |
| Amicogen | 64.82B |
| ENCell | 51.73B |
| GeneOne Life Science | 48.42B |